ATE296115T1 - Ortsspezifische arzneimittel verabreichung - Google Patents
Ortsspezifische arzneimittel verabreichungInfo
- Publication number
- ATE296115T1 ATE296115T1 AT98903970T AT98903970T ATE296115T1 AT E296115 T1 ATE296115 T1 AT E296115T1 AT 98903970 T AT98903970 T AT 98903970T AT 98903970 T AT98903970 T AT 98903970T AT E296115 T1 ATE296115 T1 AT E296115T1
- Authority
- AT
- Austria
- Prior art keywords
- site
- drug administration
- specific drug
- compounds
- localization
- Prior art date
Links
- 238000001647 drug administration Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 238000004873 anchoring Methods 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- 230000004807 localization Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
- A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4291197P | 1997-02-20 | 1997-02-20 | |
| US6663597P | 1997-11-11 | 1997-11-11 | |
| PCT/CA1998/000133 WO1998036777A1 (en) | 1997-02-20 | 1998-02-19 | Site-specific drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE296115T1 true ATE296115T1 (de) | 2005-06-15 |
Family
ID=26719776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98903970T ATE296115T1 (de) | 1997-02-20 | 1998-02-19 | Ortsspezifische arzneimittel verabreichung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060009375A1 (de) |
| EP (1) | EP0966304B1 (de) |
| JP (1) | JP2001513081A (de) |
| AT (1) | ATE296115T1 (de) |
| AU (1) | AU735791B2 (de) |
| CA (1) | CA2281493A1 (de) |
| DE (1) | DE69830305T2 (de) |
| IL (1) | IL131445A0 (de) |
| NZ (1) | NZ337924A (de) |
| WO (1) | WO1998036777A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19926154A1 (de) | 1999-06-09 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung |
| US7939087B2 (en) | 2000-10-27 | 2011-05-10 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from Streptococcus groups A & B |
| IL161673A0 (en) * | 2004-04-29 | 2004-09-27 | Applied Research Systems | Compositions and methods for therapy of chemotherapy-induced neuropathy |
| EP1832575A1 (de) * | 2006-03-06 | 2007-09-12 | Sulfidris S.r.l. | Entzündungshemmende Mittel |
| US8287885B2 (en) | 2007-09-12 | 2012-10-16 | Novartis Ag | GAS57 mutant antigens and GAS57 antibodies |
| ITMI20072215A1 (it) * | 2007-11-22 | 2009-05-23 | Sulfidris S R L | Nuovi composti anticancro |
| EP2739314B1 (de) * | 2011-08-02 | 2019-05-22 | Alfasigma S.p.A. | Pharmazeutische zusammensetzung von oxidiertem avidin, die zur inhalation geeignet ist |
| US11315181B2 (en) | 2014-12-31 | 2022-04-26 | Chicago Mercantile Exchange Inc. | Compression of price data |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4386026A (en) * | 1981-04-20 | 1983-05-31 | Merck & Co., Inc. | Cell-specific glycopeptide ligands |
| CA2016584C (en) * | 1989-05-17 | 1999-06-29 | Robert S. Greenfield | Anthracycline conjugates having a novel linker and methods for their production |
| US5612034A (en) * | 1990-10-03 | 1997-03-18 | Redcell, Inc. | Super-globuling for in vivo extended lifetimes |
| AU662155B2 (en) * | 1991-05-10 | 1995-08-24 | Celtrix Pharmaceuticals, Inc. | Targeted delivery of bone growth factors |
| US5723589A (en) * | 1995-12-21 | 1998-03-03 | Icn Pharmaceuticals | Carbohydrate conjugated bio-active compounds |
| US5840733A (en) * | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
-
1998
- 1998-02-19 IL IL13144598A patent/IL131445A0/xx unknown
- 1998-02-19 AU AU62027/98A patent/AU735791B2/en not_active Ceased
- 1998-02-19 AT AT98903970T patent/ATE296115T1/de not_active IP Right Cessation
- 1998-02-19 JP JP53611498A patent/JP2001513081A/ja not_active Ceased
- 1998-02-19 WO PCT/CA1998/000133 patent/WO1998036777A1/en not_active Ceased
- 1998-02-19 NZ NZ337924A patent/NZ337924A/xx unknown
- 1998-02-19 EP EP98903970A patent/EP0966304B1/de not_active Expired - Lifetime
- 1998-02-19 DE DE69830305T patent/DE69830305T2/de not_active Expired - Fee Related
- 1998-02-19 CA CA002281493A patent/CA2281493A1/en not_active Abandoned
-
2005
- 2005-04-27 US US11/116,943 patent/US20060009375A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ337924A (en) | 2002-09-27 |
| AU6202798A (en) | 1998-09-09 |
| EP0966304B1 (de) | 2005-05-25 |
| DE69830305T2 (de) | 2006-02-02 |
| US20060009375A1 (en) | 2006-01-12 |
| CA2281493A1 (en) | 1998-08-27 |
| EP0966304A1 (de) | 1999-12-29 |
| DE69830305D1 (de) | 2005-06-30 |
| IL131445A0 (en) | 2001-01-28 |
| AU735791B2 (en) | 2001-07-12 |
| JP2001513081A (ja) | 2001-08-28 |
| WO1998036777A1 (en) | 1998-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20053474B (en) | Glucocorticoid Receptor Modulators | |
| BR9912694A (pt) | Composto para preparar medicamento de administração pulmonar | |
| LU91037I2 (fr) | Somatulina autogel | |
| TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
| EP0382077A3 (de) | Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus | |
| NO975931D0 (no) | Blanding for administrering av medikament | |
| HU229443B1 (en) | Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use | |
| LTIP1731A (en) | Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation | |
| MY118828A (en) | Substituted amino compounds and their use as substances having an analgesic effect | |
| PT921787E (pt) | Regime de administracao de inibidores de atpase de h',k' | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| MX9706605A (es) | Derivados de indol como antagonistas de los aminoacidos exitadores. | |
| GEP20012516B (en) | Tricyclic Compounds Having Activity Specific for Integring, Particularly , avB3 Integrins, Method for Preparation the Same as Drugs and Pharmaceutical Composition Containing Same | |
| DE69824313D1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
| HUP9801128A2 (hu) | Fukopeptidek, eljárás azok előállítására és alkalmazására, valamint ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE296115T1 (de) | Ortsspezifische arzneimittel verabreichung | |
| DE69434652D1 (de) | Antikonvulsive pseudofructopyranose sulfamate | |
| NO975140D0 (no) | Transdermalt terapeutisk system (TTS) for administrasjon av testosteron | |
| HUP9702448A2 (hu) | Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény | |
| MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
| GEP20043225B (en) | 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives | |
| CA2331414A1 (en) | Transdermal therapeutic system for the administration of candesartan | |
| GB1487638A (en) | Dibenzo-(b,d)pyran dispersions | |
| GB9420748D0 (en) | 1,5 benzodiazepine derivatives | |
| ATE399173T1 (de) | Pharmazeutische zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |